M42 and Arsira to localize pharma in Abu Dhabi

M42 Company signed a memorandum of understanding with Arsera Life Sciences to strengthen the localization of biopharmaceutical industries in Abu Dhabi, aiming to develop innovative therapeutic solutions and improve access to healthcare. The collaboration focuses on utilizing genomic data, accelerating clinical development, and adopting artificial intelligence to support research and development in the fields of genetic and rare diseases, thereby enhancing Abu Dhabi’s position as a global hub for life sciences.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل